Under construction – not a live service

Skip to content

Frontlight Research

Trial site

MUDr. Jan Kvasnicka CSc

Prague 10, 101 00, CzechiaEU-13 widening countryNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Atrial fibrillation
Stroke

Running trials

Active, not recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
NCT04755283· Phase 2· Anthos Therapeutics, Inc.· Source

Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026

Report an error

Under construction, not live – MUDr. Jan Kvasnicka CSc: trial site – Frontlight Research